Medication info

Dolma Injection (Tramadol Hydrochloride)

Prescription medicationInjectionsIntramuscular injection · Intravenous injection
Ingredient · strength
Tramadol Hydrochloride›50mg / 1mL
Manufacturer / importer
Mirae Bio Pharmaceutical Co., Ltd.
Appearance
Injection containing a colorless liquid in a brown ampoule
Packaging
1ml×50 ampoules
Approval status
Active

MFDS item code 199702548 · Notified 1997.03.28 · Insurance code 657502161

Summary

Main use
Relief of pain after diagnosis or surgery and moderate to severe acute or chronic pain (e.g., cancer pain)
Who receives it
Adults
Adult administration
The dose of this medicine should be adjusted according to the patient's pain intensity and clinical response. In general, administer the lowest dose that relieves the pain. Adults Administer 50-100mg of tramadol hydrochloride intravenously or intramuscularly per dose, then repeat every 4-5 hours as needed. A maximum of 400mg may be administered daily. Elderly No dose adjustment is necessary for patients 75 years of age or younger without clinically confirmed hepatic or renal impairment. In patients over 75 years of age, elimination of this medicine may be delayed; adjust the dosing interval as needed. Patients with renal impairment/on dialysis or hepatic impairment Elimination of this medicine may be delayed in patients with renal or hepatic impairment; therefore, consider extending the dosing interval in these patients.

Ingredients

Manufacturer
Mirae Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of pain after diagnosis or surgery and moderate to severe acute or chronic pain (e.g., cancer pain)

  • Moderate to severe acute and chronic pain
  • various cancer pains
  • postoperative pain
  • pain after diagnosis
View approved original text

This medication is used to relieve moderate to severe acute or chronic pain, particularly pain caused by various cancers and pain that occurs after diagnosis or surgery.

How it is given

Adult administration

The dose of this medicine should be adjusted according to the patient's pain intensity and clinical response. In general, administer the lowest dose that relieves the pain. Adults Administer 50-100mg of tramadol hydrochloride intravenously or intramuscularly per dose, then repeat every 4-5 hours as needed. A maximum of 400mg may be administered daily. Elderly No dose adjustment is necessary for patients 75 years of age or younger without clinically confirmed hepatic or renal impairment. In patients over 75 years of age, elimination of this medicine may be delayed; adjust the dosing interval as needed. Patients with renal impairment/on dialysis or hepatic impairment Elimination of this medicine may be delayed in patients with renal or hepatic impairment; therefore, consider extending the dosing interval in these patients.

Precautions

This medication may cause seizures if the recommended dosage is exceeded, so it is essential to adhere to the prescribed dosage. Patients with epilepsy or a risk of seizures should use this medication only when necessary. Prolonged use of this drug may lead to psychological and physical dependence, so patients at risk of drug abuse must be strictly monitored for a short duration. Caution is required when taken with alcohol or central nervous system depressants, as dangerous side effects such as severe sedation or respiratory depression may occur. Individuals who metabolize this medication rapidly due to genetic factors may have a higher risk of respiratory depression, requiring dose adjustments and symptom monitoring. This medication should not be used in children under 12 years old or in adolescents under 18 years old who have undergone specific surgeries, as there is a high risk of respiratory depression. When using injections, handle the container cautiously to prevent glass particle contamination, particularly with children and the elderly. This medication should not be administered to certain patients, including those with acute alcohol intoxication, central nervous system drug overdose, severe respiratory depression, head trauma, or brain lesions. Patients with severely impaired liver or kidney function, pregnant or nursing women, and those with specific allergies should avoid this medication. Concurrent use of this medication with others may increase the risk of side effects due to interactions, so it is crucial to consult a physician or pharmacist before use. Drowsiness and dizziness may occur during treatment, so avoid driving or operating dangerous machinery. During treatment, monitor carefully for abnormal symptoms such as seizures, respiratory depression, or hypersensitivity reactions, and inform medical professionals immediately if any unusual symptoms arise. In the case of overdose, severe respiratory depression and seizures may occur, requiring emergency treatment, with naloxone as a possible antidote. This medication may have restrictions or require caution based on specific age groups and conditions such as children, adolescents, the elderly, pregnant and nursing women; thus, it is essential to take it under the guidance of a professional.

Side effects

  • Cramps
  • seizures
  • hypersensitivity
  • shock
  • anaphylaxis
  • itching
  • hives
  • bronchospasm
  • angioedema
  • respiratory depression
Show 76 more
  • dyspnea
  • asthma exacerbation
  • hiccups
  • palpitations
  • coldness
  • mimicry concern
  • vasodilation
  • hypotension
  • arrhythmia
  • facial pallor
  • syncope
  • orthostatic hypotension
  • tachycardia
  • bradycardia
  • hypertension
  • drowsiness
  • sleep
  • headache
  • heaviness in the head
  • excitement
  • tremors
  • tinnitus
  • numbness in both hands
  • anxiety
  • exhaustion
  • fatigue
  • apathy
  • sweating
  • dizziness
  • staggering
  • discomfort
  • urinary retention
  • dry mouth
  • thirst
  • confusion
  • coordination disorder
  • right-sided limb weakness
  • restlessness
  • sleep disorder
  • cognitive impairment
  • hallucinations
  • amnesia
  • concentration disorder
  • depression
  • changes in appetite
  • sensory disturbances
  • epileptic seizures
  • involuntary muscle contractions
  • muscle weakness
  • urinary obstruction
  • frequent urination
  • menopausal syndrome
  • urinary dysfunction
  • menstrual disorders
  • Stevens-Johnson syndrome
  • skin reactions
  • dependence
  • hallucinations
  • confusion
  • sleep disorder
  • anxiety
  • nightmares
  • elevated liver enzyme levels
  • hypoglycemia
  • fever
  • warmth
  • chills
  • cold sensations
  • visual disturbances
  • taste disturbances
  • weight loss
  • irritation at the injection site
  • allergic reactions
  • panic attacks
  • severe anxiety
  • sensory abnormalities

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container to protect it from air exposure, at room temperature between 1°C and 30°C. This will help maintain the drug's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Injection containing a colorless liquid in a brown ampoule

Package unit

1ml×50 ampoules

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.